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mith the increasing number of excellent papers related to
ongenital heart disease, it has become more difficult to select
hose that are perceived to be particularly critical to scientific
evelopments in the field. I have chosen in this review to focus
lmost entirely on results and to follow surgical- or catheter-
ased interventions that highlight the complex conditions
hat surgeons and cardiologists now are able to repair or
alliate successfully. Sections chosen are tetralogy of Fallot
TOF), Fontan operation, cardiac surgery in general, trans-
osition of the great arteries (TGA), hypoplastic left heart
yndrome (HLHS), aortic valve surgery, aortoplasty, and
entricular septal defect (VSD) management. These partic-
lar areas were chosen because of the importance to the
eneral field of congenital heart disease, and many of the
reas highlighted continue to plague investigators as they
ttempt to improve long-term outcomes.
OF
apers about TOF include issues related to initial interven-
ion assessment of pulmonary regurgitation (PR) timing of
ulmonary valve replacement (PVR) as well as late
ollow-up and implication for management.
Tamesberger et al. (1) reported 90 consecutive infants
ho underwent early repair: 25 neonates repaired due to
uct-dependent pulmonary circulation or severe hypoxemia
nd 65 infants 4 months old with elective repair. Their
esults indicated no 30-day mortality, and late mortality of
% with median follow-up of 4.7 years. Seven of 88 (8%)
eeded reoperation and 12 of 88 required reintervention.
he younger patients did not differ significantly in intensive
are unit stay, ventilator days, hospital stay, complications,
r reoperation. There were more frequent transannular
atches and reinterventions in the younger infants. These
re excellent results, but will such early repair result in more
evere PR and the need for more frequent PVR?
Dohlen et al. (2) reported right ventricular outflow tract
VOT) stenting in 9 infants because of cyanosis or duct-
ependency and adverse risk factors. Stenting improved O2
aturation from 73% to 94%. Median left pulmonary artery
PA) z-score increased from 4.9 to 1.5, right PA
rom the Division of Pediatric Cardiology, Vanderbilt Children’s Hospital, Nashville,
ennessee.r
Manuscript received July 1, 2009; revised manuscript received August 17, 2009,
ccepted August 24, 2009.ncreased from 3.7 to 0.8, and Nakata index increased
rom 56 to 150 mm2/m2. There were no procedural com-
lications. Six patients have undergone repair with no
eaths. This is another method to palliate infants who are
uct-dependent with adverse risk factors and have a pulmo-
ary valve that is deemed unsalvageable. Stenting allows
nfants to obtain a greater age and size when repair
heoretically is safer.
Papadopoulos et al. (3) reported repair of pulmonary
alves in 5 children and 2 adults. All had severe PR
ssociated with right ventricular (RV) dilation and dysfunc-
ion after primary right VOT reconstruction. There were no
perative or late deaths. All valves were repaired successfully
ith a mean PR grade of 1.3 post-operatively. Mean
ransvalvular gradient was 20 mm Hg for children and 23
m Hg for adults. The mean RV dilation index decreased
ignificantly from 0.85 to 0.6 for children and 1.4 to 0.9 for
dults. No significant regurgitation of the reconstructed
alve was observed in the 4-year follow-up. This may prove
o be an alternative to PVR in selected patients.
van den Berg et al. (4) reported on biventricular (BV)
eserve, N-terminal pro–B-type natriuretic peptide (NT-
roBNP) levels, and exercise performance in relation to RV
olume in 53 patients with PR after repair with a maximum
ge of 2 years at repair; interval since repair was 15 years
ith no residual lesions except PR. The mean RV end-
iastolic volume was 140 ml/m2. Median PR fraction was
7%. BV systolic stress response was normal, stroke volume
ncreased, and no adverse effects to dobutamine infusion
ere encountered. NT-proBNP was increased in 2 patients,
edian level 10 pmol/l and levels correlated with PR
ercentage but not with RV size. Mean peak exercise O2
onsumption (VO2max) was 96% of normal, and mean
orkloadmax was 89% of predicted. At midterm follow-up,
T-proBNP levels are normal and BV functional reserve
nd exercise tolerance are well preserved in TOF repaired at
oung age, irrespective of RV volume. This study questions
he validity of isolated PR or RV volume criteria for PVR in
his group. Low-dose dobutamine stress testing is well
olerated and may be a useful additional tool for decision
aking. These data indicate that age of repair may play a
rucial role in the adaptation of the RV to volume load and
ay change the indications for PVR in those with early
epair.
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Year in Congenital Heart Disease January 12, 2010:147–55Knauth et al. (5) assessed ventricular size and function by
ardiac magnetic resonance (CMR) as predictors of clinical
utcomes after repair in 88 patients. The median time from
epair to evaluation was 21 years, and median follow-up
rom baseline to most recent follow-up was 4 years. Adverse
utcomes included death, sustained ventricular tachycardia
VT), and increase in New York Heart Association func-
ional class to grade III or IV. Adverse outcomes occurred in
8 patients or 21%, death in 4, sustained VT in 8, and
ncrease in New York Heart Association functional class in
0. Severe RV dilation and either left ventricular (LV) or
V dysfunction predicted major adverse clinical events.
his information may help assist in terms of therapeutic
nterventions. It should be noted that age at repair and era
f surgery also correlated with adverse outcomes although
hese effects were theoretically controlled for in the statis-
ical models used in determining the effects of RV size and
entricular function.
Harrild et al. (6) studied 98 adults with late PVR for RV
ilation. Matched controls were identified for 77 of these
atients; controls had TOF with RV dilation and no PVR.
atching was done by age and baseline QRS duration. In
he PVR group, 13 events occurred over 272 patient-years.
n the matched comparison, no significant differences were
een in VT, death, or combined VT and/or death. This
ohort experienced either VT or death every 20 patient-
ears, and in a matched comparison with a similar TOF
roup, late PVR for symptomatic PR/RV dilation did not
educe the incidence of VT or death. These results can help
o guide expectations of patients and physicians alike; PVR
an be performed too late to prevent a tragic outcome.
Godart et al. (7) used off-pump PVR with a self-
xpandable valve stent as an emerging technique in 15 lambs
y direct access of the infundibulum through a left thora-
otomy, combined with PA banding. Animals were fol-
owed by transesophageal echocardiography and after con-
rol hemodynamic study, were electively sacrificed (at day 7,
onth 1, or month 4). Two animals died after implantation
1 of pneumothorax and 1 of endocarditis). Doppler studies
howed only mild PR. Systolic gradients were 18 mm Hg at
week, 13 mm Hg at 1 month, and 4 mm Hg at 4 months.
xamination demonstrated connective tissue between the
tent and pulmonary wall, which increased with time. This
ew hybrid approach using a porcine valve mounted in a
elf-expandable stent to replace the pulmonary valve, with-
ut cardiopulmonary bypass (CPB), can theoretically reduce
orbidity and the potential for myocardial damage during
pen heart surgery.
ontan Operation
ngoing important studies continue to be related to post-
ontan natural history, methods of Fontan repair, flow
ynamics, and evaluation before and after Fontan repair.
Shiraishi et al. (8) studied the impact of age at Fontanrocedure completion on post-operative hemodynamics and 4xercise in 68 patients with a dominant LV. Patients
nderwent exercise testing and catheterization at 1 year and
hen every 5 years and were divided into Group A 3 years
t repair and Group B 3 years. No patients died during
ollow-up of 91 months. VO2max was 61% of normal in
roup A versus 52% of normal in Group B, and cardiac
ndex was 3.3 versus 2.4 at 5 years and 3.3 versus 2.6 at 10
ears. The LV ejection fraction (EF) at 10 years was 62
ersus 53%, all higher in the younger group. Here is another
ote for an earlier Fontan procedure to achieve a beneficial
ffect on exercise capacity and hemodynamics in patients
ith a dominant LV.
Kerendi et al. (9) reviewed 236 consecutive Fontan
rocedures; Group 1 (n  21) had concomitant atrioven-
ricular valve (AVV) repair or replacement as compared with
roup 2 (n  215) with no AVV surgery. AVV regurgita-
ion was graded as 1 (none or trivial) to 4 (severe). Group 1
atients were older (4 years vs. 3 years) and had longer CPB
imes (118 min vs. 85 min) and aortic cross-clamp times (33
in vs. 14 min). There were no differences between groups
n diagnosis, weight, hospital or intensive care unit stay,
entilator time, or 12-h chest tube output. Post-operative
omplications were similar between groups, including bleed-
ng, neurologic injury, arrhythmias, and operative mortality.
here was a significant decrease of AVV regurgitation after
urgery (3 pre-operatively vs. 1.7 post-operatively). Success-
ul AVV surgery can improve operative and late outcomes
or single-ventricle patients. This study demonstrates that
VV surgery performed with the Fontan procedure in-
reased operative times, but did not significantly increase
orbidity or mortality and supports the use of AVV surgery
or single-ventricle patients.
Ovroutski et al. (10) reported on 35 patients in whom
ontan operation was performed at a median age of 4.2
ears and underwent angiographic measurements of the
entral and lower lobe PA diameter before and during a
edian follow-up of 4.6 years. Although somatic develop-
ent was documented by body surface area measurements,
he PA showed no gain in diameter, and PA and lower lobe
ndexes decreased significantly during follow-up. This phe-
omenon may lead to a gradual increase in pulmonary
ascular impedance and could be a limiting factor for
ptimal Fontan circulation long term. This report empha-
izes again the importance of PA size before operation.
Bacha et al. (11) reported on 49 patients who underwent
onnection of discontinuous PAs with or after a bidirec-
ional Glenn (n  29) or Fontan (n  20) procedure at a
edian age of 7.9 years. The PA continuity was established
y direct anastomosis in 27, interposition graft in 19, and
ranscatheter recanalization in 3. Survival was 92% at 1 year
nd 89% at 5 years. Recurrent PA occlusion was docu-
ented in 7 patients, 5 within 10 days of PA connection.
he only factor associated with shorter freedom from PA
cclusion was sole supply of blood flow to 1 lung by
ystemic-to-PA collaterals before connection. Among the
5 early survivors, freedom from PA reintervention or
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January 12, 2010:147–55 Year in Congenital Heart Diseasecclusion was 83% at 1 year and 55% at 3 years. Discon-
inuous PAs can be successfully reconnected in most pa-
ients with a cavopulmonary connection, although noncon-
uent PAs increase the risk of poor outcome after Fontan
peration. The fact that recurrent PA occlusion was usually
iagnosed early post-operatively indicates that early restudy
s useful in all patients with less than optimal results. In
atients with sole blood supply to 1 lung through collaterals,
hunt placements before PA connection may optimize
utcome.
Anderson et al. (12) from the Pediatric Heart Network
ulticenter study reported on contemporary outcomes after
he Fontan procedures in 546 children. Predominant ven-
ricular morphology was 49% LV, 34% RV, and 17% mixed.
jection fraction was normal for 73% of subjects; diastolic
unction grade was normal for 28%. Child Health Ques-
ionnaire scores were lower than for controls; however, over
0% of subjects were in the normal range. The BNP
oncentration ranged from –4 to 652 pg/ml. Mean percent
O2max was 65% and decreased with age. Ejection fracture
nd EF z-score were lowest and semilunar and AVV
egurgitation were more prevalent in the RV subgroup.
lder age at the time of the Fontan procedure was associ-
ted with more severe AVV regurgitation. Measures of
entricular systolic function and functional health status,
lthough lower on average in the cohort compared with
ontrol subjects, were in the majority within 2 SDs of the
ean for controls. The RV morphology was associated with
oorer ventricular and valvular function. Effective strategies
o preserve ventricular and valvular function, particularly for
atients with RV morphology, are needed.
Kim et al. (13) reported on 114 patients who underwent
uperior vena cava-to-PA anastomosis as an adjunct to BV
epair in patients with a questionably adequate pulmonary
entricle; median follow-up was 92 months. Patient groups
ere determined by small pulmonary ventricles, chronic
ulmonary ventricle dysfunction facilitation of repair with-
ut ventricular dysfunction or functional problems of the
ulmonary ventricles, and acute pulmonary ventricular dys-
unction. The long-term outcome for operative survivors
as 83%, 80%, and 69% at 5, 10, and 20 years respectively.
urvival in the previous 10 years was 92%. Of the late
eaths, 70% were known cardiac deaths or sudden. Patients
ith chronic pulmonary dysfunction demonstrated the best
0-year survival. Of the late survivals, 98% of patients are in
ew York Heart Association functional class I or II.
rterial oxygen saturation increased significantly from be-
ore to late after repair, 83% to 94%. Freedom from new
trial arrhythmia was 92% at 20 years. There was no patient
ith clinically evident protein losing enteropathy. The most
ommon cause of late mortality was cardiac. Serious com-
lication risk related to pulsatility in the superior vena cava
as only 2.6%. This procedure usually relates to a small or
ysfunctional RV and is an important adjunct for the 1.5
entricle repair. Complications related to superior vena cava hymptoms were rare and atrial defects usually closed spon-
aneously or by percutaneous occlusion.
ardiac Surgery/General
hese articles relate to congenital heart surgical outcomes
or various diagnoses, complications of procedures, hybrid
pproaches, and practice patterns.
Polito et al. (14) reported the associations between
ntraoperative and early post-operative glucose levels and
dverse outcomes after complex surgery for 378 consecutive
igh-risk patients. Intraoperatively, a minimum glucose
75 mg/dl was associated with greater adjusted odds of
eaching the composite morbidity-mortality end point (odds
atio [OR]: 3.10). Greater duration of hyperglycemia (glu-
ose: 126 mg/dl) during the 72 post-operative hours was
ssociated with longer duration of hospitalization. In the
2 h after surgery, average glucose 110 or 143 mg/dl,
inimum glucose 75 mg/dl, and peak glucose level 250
g/dl were all associated with greater adjusted odds of
eaching the composite morbidity-mortality end point. In
hildren undergoing complex surgery, optimal, post-
perative glucose range is probably 110 to 126 mg/dl and
ay require insulin infusions to achieve optimal outcomes.
e usually think more about cardiac output, lactate levels,
nd low O2 as indications for poor outcomes after surgery.
his article showed that glucose levels may also be impor-
ant and require tighter control than was previously prac-
iced for optimal results.
Domi et al. (15) performed a case-control study of
hildren from term birth to 18 years with congenital heart
isease who underwent open heart surgery between January
992 and March 2001 to document frequency, predictors,
nd neurologic outcomes of vaso-occlusive strokes. Case
ubjects experienced stroke within 72 h after surgery and
ontrol subjects (2 for each case subject) had surgery and no
troke. There were 30 children with stroke (28 with arterial
schemic stroke and 2 with cerebral sinovenosus thrombosis)
ho were identified among 5,526 children undergoing
ardiac surgery yielding a risk for stroke of 5.4 per 1,000
hildren. Univariate analysis revealed that older age, longer
uration of CPB, number of days in the hospital post-
peratively, and reoperation were associated with stroke. In
ultivariate analyses, only reoperation was associated with
troke. Obviously, stroke is a devastating issue in children
ndergoing surgery, most of whom survive surgery and have
good cardiac outcome. In survivors, neurologic deficits
ere present in 72%, and 14% died after their stroke; only
4% had normal neurologic outcomes. Neurologic deficits
nclude seizure disorder, headache disorder, as well as
hysical deficits. Patients with stroke were investigated for
isk factors in addition to cardiac surgery. Prothrombotic
bnormalities were found in 6% who tested positive for
actor V Leiden mutation, 20% who tested positive for
nticardiolipin antibody at least once, and 13% had a family
istory of thrombosis. Congenital and acquired prothrom-
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Year in Congenital Heart Disease January 12, 2010:147–55otic conditions may predispose patients to cerebral throm-
osis and emboli. The study had insufficient power to
dentify predictors of stroke and potential preventative
trategies. This is an important area of research and hope-
ully further studies can point to ways to decrease this
evastating outcome of cardiac surgery.
Karamlou et al. (16) reported on practice patterns for
anagement of adult congenital heart disease. These
nvestigators identified patients with 12 congenital heart
isease diagnostic groups using the Nationwide Inpatient
ample 1988 to 2003. Pediatric heart surgeons were
dentified as surgeons whose annual practice volumes
ere 75% pediatric heart cases. Operations on adults
ere identified within these 12 diagnoses occurring in
atients 18 years of age. There were 30,250 operations
ielding a national estimate of 152,277; 73% were pedi-
tric operations and 27% were adult congenital heart
isease operations. Pediatric heart surgeons performed
8% of pediatric operations in all diagnostic groups,
hereas nonpediatric heart surgeons performed 95% of
dult operations within the same groups. In-hospital
ortality for adults operated on by pediatric heart sur-
eons were lower than that for patients operated on by
onpediatric heart surgeons: 1.87% versus 4.84%. Sur-
ival advantage increased with increasing annual pediatric
olume.
Debate continues about how best to care for adult
ongenital heart patients. There are both pediatric and adult
nstitutions that can show outstanding outcomes as long as
hey are equipped in terms of operating rooms, surgical and
ncillary staff, and intensive care staff with training and
xperience to take care of them in either place. Familiarity
ith the type of complex anatomy one frequently is dealing
ith in these adult patients is critically important, and
ediatric heart surgeons usually have this expertise to yield
etter outcomes.
Menon et al. (17) reported on hybrid intraoperative PA
tent placement in 24 patients with a median age of 15
ears (range 3 to 67 years). A total of 27 stents were
eployed: left PA stent in 13, right PA stent in 8, and
ilateral stents in 3 patients. Primary diagnoses were
ulmonary atresia, TOF, tricuspid atresia, and other
ore complex conditions. Maximum balloon diameters
anged from 8 to 16 mm. Concomitant surgical proce-
ures performed were RV to PA conduit replacement or
ight VOT reconstruction, PVR, and others. There were
o deaths or PA damage. There were 2 cases of distal
tent migration. Repeat stent dilations within 6 months
ere performed in 3 patients. Hybrid PA stenting can
lay an important role in the management of congenital
eart disease with complex branch PA anatomy and can
lso be used as a rescue procedure following complica-
ions of percutaneous transcatheter procedures, such as
tent embolization, which can be prevented by suturing
he proximal end of the stent to the PA. There was no
ncidence of stent migration since this technique was Mnstituted. The use of expandable stents may alleviate
ome of the questions about future intervention. Hybrid
rocedures are best carried out in a suite with biplane
ngiography available.
Vida et al. (18) studied patent ductus arteriosus ligation in
remature babies with the question of optimal timing for
urgical ligation. There were 201 premature babies (32
eeks gestation) from 2001 to 2007 who received primary
edical treatment with ibuprofen. Medical treatment was
ffective in 149 patients, but 52 required surgical ligation
fter medical failure. Most who failed were younger, had
ower weight, and had a higher incidence of symptomatic
ypotension. More than 2 cycles of ibuprofen were associ-
ted with an increased risk for bronchopulmonary dysplasia
OR: 2.8) and acute renal failure (OR: 3.81). Prolonged
atency of the ductus in pre-term infants is related to
ncreased morbidity. Frequently, it is a difficult decision as
o when to proceed with patent ductus arteriosus ligation in
premature infant, particularly in those who weigh 750 g or
ess. This study shows that more than 2 cycles of ibuprofen
re not in the patient’s best interest, and in this situation,
atients should have their patent ductus arteriosus ligated.
Lim et al. (19) reported on the results in 2 patients with
eterotaxy syndrome who underwent BV repair from 1990
o 2007. Left atrial isomerism was present in 73% and right
trial isomerism in 10%, with indeterminate atrial anatomy
n 17%. Median age at repair was 6.8 months with a range
f 5 days to 22 years. Systemic venous anomalies were
resent in 75 patients, pulmonary venous anomalies in 26,
nd endocardial cushion defects in 36. Operations included
ouble switch repair, physiologic repair, arterial switch, and
he Rastelli procedure. Separation of systemic from pulmo-
ary venous return included intra-atrial baffle in 48 patients
nd extracardiac grafting in 2. Combined lesions were
ommon, occurring in 99% of patients. Average follow-up
as 45 months. Survival was 93% at 10 years; unbalanced
trioventricular canal was the only risk factor for mortality.
ubsequent procedures were common with a 10-year free-
om from reoperation or reintervention of 38%. Arrhyth-
ias occurred in 40%, bradyarrhythmia in 30%, and tachy-
rrhythmia in 16% of patients. Freedom from any
rrhythmia was 54% at 10 years. Despite complex anato-
ies, these patients should be better off in most cases with
BV versus Fontan operation when feasible.
GA
ollow-up and natural history of patients undergoing atrial
nd arterial switch procedures are of considerable impor-
ance, as detailed in the following articles.
Hörer et al. (20) compared survival, freedom from reop-
ration, and functional status between atrial switch and
rterial switch operations. There were 88 Mustard patients,
29 Senning procedures, and 512 arterial switch operations
etween 1974 and 2006. In-hospital mortalities were 8% for
ustard, 4.6% for Senning, and 6.4% for arterial switch.
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January 12, 2010:147–55 Year in Congenital Heart Diseaseresence of VSD was the only risk factor for in-hospital
ortality in multivariate analysis. Highest survival at 20
ears was after arterial switch (96%), followed by Senning
rocedure (93%), and Mustard operation (82%). TGA with
SD, TGA with VSD plus left VOT obstruction, and
ustard operation emerged as risk factors for late death,
ith arterial switch as a protective factor. Highest freedom
rom reoperation at 20 years was after Senning procedure,
ollowed by arterial switch and Mustard operation. Presence
f complex transposition, previous palliative operation, sur-
ery between 1985 and 1995, surgery after 1995, and
ustard operation emerged as risk factors for reoperation.
hange from atrial to arterial switch led to improved
ong-term survival after hospital discharge but not to lower
ncidence of reoperation. This excellent documentation of a
arge number of patients followed before and after the
hange from atrial to arterial switch operation shows the
uspected improvement in survival and functional status at
his point 10 years out. It is interesting that the Senning
atients do much better than Mustard patients do. This is
robably because many Senning patients were operated on
t a younger age and in an era of improved intraoperative
yocardial protection. The fact that the arterial switch
atients had a greater reoperation rate is due to the
ulmonary stenosis problem early in the use of this opera-
ion as has been noted by other groups and has largely been
ircumvented by changes in the technique to reconstruct the
ulmonary arteries.
Bové et al. (21) reported on 93 children who were
eviewed for functional and morphologic assessment of both
econstructed arteries after the arterial switch. At a mean
ollow-up of 5 years, aortic regurgitation (AR) 2 devel-
ped in 10% in TGA with intact ventricular septum versus
3% in TGA with VSD. Neoaortic obstruction occurred in
%, mostly at the neosinotubular anastomosis, and corre-
ated with prior pulmonary to aortic ratio 1.5. Freedom
rom reintervention at 1, 5, and 10 years was 98%, 96%, and
6%, respectively, for TGA/intact ventricular septum versus
5%, 63%, and 63%, respectively, for TGA/VSD. An aortic
rch obstruction and VSD were significant predictors for
eintervention. After arterial switch operation, the neoaortic
oot is usually enlarged, but with a growth pattern compa-
able to that of a normal population. The presence of a VSD
nd larger aortic root size predisposes to both neoaortic
alve dysfunction and root enlargement. Severe root dilation
ppears to be closely related to significant neoaortic valve
egurgitation, as a result of a time-dependant and reciprocal
rocess. Neopulmonary stenosis is a frequent finding, but
arely has clinical consequences. Significant AR reported
ere is of concern. This appears to be brought on mainly by
he enlarged aorta at the time of operation usually associated
ith VSD and neoaortic obstruction. Although the PA
ppears to take on the characteristics of a normal aorta with
ime, particularly in those with younger age of operation,
here still can be significant size discrepancy, which leads to Angoing AR. Hopefully, this will stabilize and not require a
arge number of patients requiring aortic valve surgery.
Petit et al. (22) reported follow-up after balloon atrial
eptostomy (BAS) for TGA. Twenty-six infants with TGA
ere retrospectively included from a larger cohort of infants
ith congenital heart disease who underwent pre-operative
rain magnetic resonance imaging as part of 2 separate
rospective studies. Data collected included all pre-
perative pulse oximetry recordings, all values from pre-
perative arterial blood gas measurements, and BAS pro-
edure data. Magnetic resonance imaging scans were
erformed on the day of surgery, before the surgical repair.
f the 26 infants, 14 underwent BAS. No stroke was found
n the entire cohort, whereas 10 of 26 patients were found to
ave hypoxic brain injury in the form of periventricular
eukomalacia. This problem was not associated with BAS;
owever, neonates with periventricular leukomalacia had
ower pre-operative oxygenation and a longer time to
urgery than those without periventricular leukomalacia.
learly, BAS was not associated with significant brain
njury. Theoretically, BAS could cause brain injury with
ignificant air embolus. However, this should be a rare
omplication.
Sharma et al. (23) reported on double switch operation or
ongenitally corrected TGA in 68 patients. Group 1 com-
rised 31 patients at a mean age of 94 months who
nderwent a combined Rastelli and atrial switch operation.
roup 2 comprised 37 patients with a mean age of 36
onths who underwent an arterial switch operation and
trial re-routing. Of the patients in Group 2, 8 had an intact
entricular septum. Group 1 had 5 early deaths (17%) but
o late deaths. Three patients underwent conduit revision at
mean follow-up of 62 months. Group 2 had 5 early deaths
13.5%). There were 4 late reoperations (2 pulmonary baffle
evisions, 1 mitral valve replacement, and 1 permanent
acemaker implantation) and 4 late deaths (1 secondary to
ulmonary hypertension, 2 secondary to uncontrolled atrial
achyarrhythmia, and 1 secondary to pulmonary hyperten-
ion and right ventricular failure). In Group 2, 4 patients
ad a left ventricular ejection fraction 40%, 5 had mod-
rate AR, 5 patients had symptomatic tricuspid incompe-
ence, 1 had tricuspid stenosis, 1 patient had superior cava
bstruction, and 3 patients received antiarrhythmic therapy.
his is a complex procedure and unfortunately can be
ssociated with multiple complications. One distressing
eature of this follow-up is the discovery of significant LV
ysfunction at midterm follow-up.
Scherptong et al. (24) studied the effects of tricuspid valve
urgery in 16 adults with a dysfunctional systemic RV who
nderwent tricuspid valvuloplasty in 8 or replacements in 8.
here were 9 patients with congenitally corrected TGA and
with previous atrially corrected TGA. The patient ages
veraged 35 years. Tricuspid regurgitation was graded 1 to 4
ccording to its severity, RV dysfunction was graded as to 1
o 4, with 1  no dysfunction to 4  severe dysfunction.
lthough complications occurred in 11 patients, all could be
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verall, tricuspid valve function improved from grade 3 to
.9 and functional class improved from 2.7 to 2.1, whereas
V function remained unchanged. After surgery, however,
ecurrent moderate tricuspid regurgitation was observed
requently (37%). Although this study suggests you can buy
bit of time with target vessel revascularization in patients
ith a dysfunctional systemic RV, the results are not
verwhelmingly positive. Certainly one should consider this
ossibility in patients who have only mild RV dysfunction.
nother option that may be useful is PA banding in those
ith low LV pressure as this relatively benign type of
urgery can result in improvement in tricuspid valve func-
ion and stabilization of patients. Unfortunately, rehabilita-
ion of a systemic RV is fraught with difficulty in any type
f surgical intervention in the adult and transplant may be
he best option for many patients.
LHS
pproaches to risk stratification in infants with HLHS and
utcomes continue to be of importance.
Honjo et al. (25) reported on clinical outcomes, program
volution, and PA growth in single-ventricle palliation using
ybrid and palliative strategies. In all, 58 patients underwent
orwood operation with Blalock-Taussig shunt (in 39) or
ybrid procedures (in 19). At pre-stage 2 evaluation, there were
onsignificant trends toward lower ventricular end-diastolic
ressure with higher mixed venous saturation, and larger
akata and lower lobe indexes in the hybrids. Mean PA
ressures were not different between the groups. Four Nor-
ood patients (10%) underwent transplantation before stage 2
alliation. Forty-two patients underwent stage 2 palliation or
tage 2 hybrid procedure. Requirement for PA-plasty, post-
perative central venous pressure, stage 2 survival, and 1 year
urvival were similar between groups. Combined (stage 1 plus
tage 2) intubation time, intensive care unit time, and hospital
ength of stay was shorter for hybrids than for Norwood
urvivors. Comparison of resource utilization at the time of
rch reconstruction demonstrated a time-related trend toward
mprovement in the hybrid group but not in the Norwood
roup. Hybrid palliation does not have a significant adverse
mpact on PA development, with comparable PA growth and
emodynamics. The hybrid palliative strategy has emerged as
n alternative to Norwood palliation. An intuitive but un-
roven advantage of this strategy is the avoidance of CPB and
ortic arch reconstruction in the neonatal period and deferring
hese procedures until the stage 2 procedure at 4 to 6 months
f age when the patient is hypothetically more able to tolerate
“big” operation. There are patients in whom this is not an
cceptable procedure, particularly in those who have narrowing
f the pre-ductal arch, which leads to severe acute coronary
schemia or after stent placement. It does appear that hybrid
alliation in this study showed improved RV function as
ompared with RV function of the classical Norwood group.
s noted in the discussion of this article, it may be time for a tomparison of hybrid versus standard surgery for Norwood
atients and in a large multi-institution study.
Tabbutt et al. (26) studied neurodevelopmental outcomes
fter staged palliation for HLHS at 1 year of age. Entry
riteria included all patients with single-ventricle physio-
ogic features and systemic outflow obstruction undergoing
taged palliation. Exclusion criteria before surgical interven-
ion included: 1) multiple congenital anomalies; 2) recog-
izable chromosomal or phenotypic syndrome at birth; and
) non-English language primarily spoken in the home. A
otal of 83 patients underwent multiple operations with
BP during the first year of life. The mean was 2 opera-
ions, with 7 patients requiring extracorporeal membrane
xygenation palliation post-operatively. There were 25 pa-
ients or 28% with a confirmed or suspected genetic syn-
rome. At 1 year of age, the neuromuscular examination
esults were abnormal or suspect for 65%. The mean Mental
evelopmental Index score was 90, and 10 patients had
cores 70. The median Psychomotor Development Index
as 73, and 42 patients had scores 70. In multivariate
nalyses, younger gestational age, the presence of a genetic
yndrome, the need for pre-operative intubation had signif-
cant negative effects on neurodevelopmental outcomes. No
ssociation was found with the operative factors, including
uration of deep hypothermic circulatory arrest. The study
uggests that future research should continue to focus on the
ole of perioperative management, post-discharge care, and
arly interventions. Longer-term developmental follow-up
valuation of these patients is of utmost importance and
urrently is underway. In addition, continued investigation
o identify modifiable risk factors in this high-risk group of
nfants should be supported.
Grosse-Wortmann et al. (27) used CMR in 20 consec-
tive patients with the mean age of 10 days to assess LV
olume in terms of decision-making of BV versus univen-
ricular repair. Diagnoses were aortic stenosis in 3 patients,
LHS in 12 patients, and unbalanced atrioventricular
eptal defect in 5 patients. Potential LV volumes assuming
n ideal geometric shape were calculated by mathematically
unfolding” the compressed LV. The left ventricular end-
iastolic volume (LVEDV) was 16  7.0 ml/m2 by echo-
ardiography and 33.5  15.5 ml/m2 by CMR. Echocar-
iography consistently underestimated LV volume and did
ot correlate with CMR. Of all echocardiographic param-
ters, mitral valve z-score was the best predictor of LVEDV
y CMR. The average potential volume increase was 8.8% for
ortic stenosis, 35% for atrioventricular septal defect, and 23%
or HLHS complex patients; 16 of 20 patients underwent BV
epair without mortality. Of these, only 5 had a pre-operative
VEDV of more than 20 ml/m2 by echocardiography. These
nvestigators have shown an ability to get borderline LV
olume patients through a BV operative plan by using CMR to
ore adequately estimate their volume and calculate potential
olume, which is significantly augmented particularly in atrio-
entricular septal defect and HLHS patients. It was of interest
hat mitral valve diameter and aortic annulus size were also
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January 12, 2010:147–55 Year in Congenital Heart Diseaseound to be larger by CMR than by echocardiography. This is
n unusual finding; these measurements are usually quite
ccurate by echocardiography. These findings can hopefully be
pplied to other patients with borderline situations and cor-
ectly put them into a BV repair mode when feasible. It can
bviously be disastrous to use the BV approach with patients
hose LV is really untenable for BV repair. Thus, it is critically
mportant to be accurate before proceeding with BV repair in
orderline patients.
ortic Valve Surgery and Aortopathy
ortic valve and aortic root pathology continue to be
revalent issues to deal with in the congenital heart
opulations.
Alsoufi et al. (28) studied mechanical valves versus the
oss procedure for aortic valve replacement (AVR) in 346
hildren: 215 who underwent the Ross procedure and 131
ho underwent AVR with a mechanical prosthesis. Patients
ndergoing the Ross procedure were younger, more likely to
ave a congenital cause, and less likely to have a rheumatic
r connective tissue cause. They had a lower frequency of
egurgitation, required more annular enlargement, and had
ess concomitant cardiac surgery. Competing-risk analysis
howed that 16 years after AVR, 20% had died without
ubsequent AVR, 25% underwent a second AVR, and 55%
emained alive without further surgery. After propensity
djustment, factors associated with early phase death in-
luded mechanical valves and a nonrheumatic cause. Free-
om from homograft replacement after the Ross procedure
as 82% at 16 years of follow-up. These outcomes are
onfounded somewhat from the standpoint of U.S. and
uropean patients because of the significant number with
heumatic heart disease. Survival was excellent with the
oss procedure versus mechanical AVR, particularly in
atients who had rheumatic fever. Despite the surgical
omplexity, the Ross procedure was associated with only a
.3% mortality, which is similar to data from the Interna-
ional Registry. These investigators reported a high incidence
f Ross failure in patients with active rheumatic fever at the
ime of AVR, patients with dilation of the left VOT30 mm,
nd patients with an aortic annulus of 3 mm or more larger
han the pulmonary annulus. They now offer the Ross proce-
ure exclusively in patients 5 years of age. These data show
xcellent long-term follow-up data in patients with Ross
rocedure who are nonrheumatic in origin.
Cameron et al. (29) reported on aortic root replacement
ARR) in 372 Marfan patients with an evolution of repair
ver 30 years. These investigators report that of 269 of 372
atients with a Bentall composite graft, 85 had valve-spring
RR, 16 had ARR with homografts, and 2 had ARR with
orcine xenografts. In the first 24 years of the study, 85%
eceived a Bentall graft; during the last 8 years, 61% had a
alve-sparing procedure. There was no operative or hospital
ortality among the 327 patients who underwent elective
epair; there were 2 deaths among the 45 patients who pnderwent emergent or urgent repair. There were 74 late
eaths (70 Bentalls, 2 homografts, and 2 valve-sparing
RRs). The most frequent causes of late death were
issection or rupture of the residual aorta. Prophylactic
urgical replacement of the ascending aorta in patients with
arfan syndrome has a low operative risk and can prevent
ortic catastrophe in most patients. Valve-sparing proce-
ures, particularly using the reimplantation technique with
he Valsalva graft, show promise but have not yet proven as
urable as the Bentall procedure. These investigators show
xcellent results in the evolution of this important proce-
ure. The current guidelines are for aortic root replacement
n Marfan syndrome with aortic sinus diameter 5 cm or
reater (or 4.5 cm among patients with family history of
upture or dissection); ascending aortic dissection, whether
cute or chronic; aneurysm growth more than 1 m/year; and
orsening AR in a dilated root when a valve-sparing
rocedure is desired. The results are much worse in terms of
ate complications and mortality in those who have dissec-
ion before surgery, as one might predict.
Aalberts et al. (30) reported on the many faces of
ggressive aortic pathology in Loeys-Dietz syndrome
LDS). LDS is a newly recognized disorder of connective
issue that shares overlapping features with Marfan syn-
rome and the vascular type of Ehlers-Danlos syndrome,
ncluding aortic root dilation and skin abnormalities. It can
e recognized by craniofacial characteristics, such as hyper-
elorism, bifid uvula, or cleft palate in LDS type 1, whereas
hese are absent in LDS type 2. This is a very aggressive
ortic pathology. These investigators found 9 LDS patients
rom 4 families, related their features to published cases, and
iscussed important aspects of the diagnosis and manage-
ent of LDS in order to make clinicians aware of this
yndrome. Because aortic dissection and rupture in LDS
end to occur at a younger age and because the vascular
athology can be seen throughout the entire arterial tree,
atients should be carefully followed up and aggressive
urgical treatment is mandatory. Pictures of patients in this
rticle are quite useful in terms of discovering these patients
nd treating them in an aggressive fashion.
SD Management
oshimura et al. (31) reported on surgical management of
ultiple VSDs using the felt sandwich surgical technique.
here were 29 consecutive patients who underwent an
peration for multiple VSDs and associated cardiac malfor-
ations including 17 male and 12 female infants with a
edian age of 6 months. Thirteen patients had 4 or more
SDs. There was no surgical or follow-up mortality, and no
eoperations were required. There were no cases of heart
lock and no significant residual shunts in the latest
ollow-up study. Two patients with Swiss cheese septum
ad post-operative congestive heart failure; 3 muscular
SDs were closed with a sandwich technique in those
atients. Of the other 27 patients, 7 of the 9 patients who
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Year in Congenital Heart Disease January 12, 2010:147–55nderwent the sandwich procedure had septal dysfunction,
hereas 5 of the 20 other patients showed septal dysfunc-
ion. Although the sandwich technique is simple and
ffective, the use of numerous felt patches disturbed the
ovement of the interventricular septum. An effort should
e made to close the muscular VSD directly to avoid
ost-operative cardiac dysfunction. Large apical defects,
irectly located underneath the moderator band, are con-
idered suitable for the sandwich technique. Some of these
efects can be closed with a percutaneous device; this may
rove as useful as the felt sandwich technique and may result
n less septal dysfunction, although this is unproven.
Chessa et al. (32) reported on 40 adult patients who
nderwent transcatheter closure of VSD. A shunt was
onsidered significant for closure when left atrial or LV
nlargement was found or there was a previous endocarditis.
n 40 patients, 41 procedures were carried out; a muscular
SD occluder was used in 22 patients and a perimembra-
ous VSD occluder in 18. No deaths occurred and no
rocedure was aborted. No device embolization occurred.
he median follow-up duration was 36 months with a range
f 6 to 81 months. One patient, who had 2 devices inserted
ecause of a residual defect after TOF repair, had to be
perated on again after the second device implantation
ecause of a persistent residual leak. An internal jugular
enous approach was used to close muscular VSDs
hereas femoral vein access was used to close perimem-
ranous VSDs. A total of 6 complications occurred. The
ost frequent complication was a rhythm abnormality
irectly after device implantation: 1 transient left anterior
emiblock, 1 transient complete AV block, and 2 ven-
ricular fibrillations requiring electrical defibrillation; AR
nd/or tricuspid regurgitation are potential problems in
hese cases and were reported transiently in only 2 of 41
atients. This is a procedure for experienced interven-
ionalists with surgical backup available at the time of the
rocedure.
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